NewsBenzingaVera Therapeutics presentará múltiples ponencias en la Kidney Week 2026 de la American Society of Nephrology para su análisis final de eficacia del estudio ORIGIN 3 de TRUTAKNA en la nefropatía por IgA Vera Therapeutics presentará múltiples ponencias en la Kidney Week 2026 de la American Society of Nephrology para su análisis final de eficacia del estudio ORIGIN 3 de TRUTAKNA en la nefropatía por IgA Benzinga 2026.10.02 13:28 (GMT+0) Open on Benzinga Other news BofA: US memory stock valuations show signs of cycle bottom, market concerns overblown BCX: Invest In Essential Resources, Collect 7% Monthly Income (NYSE:BCX) Tech stocks stumbled. Now comes a crucial week for Wall Street. UnitedHealth: My Thesis Has Played Out, I Wouldn't Chase Here (NYSE:UNH) OFG Bancorp: Risks Remain, But Not Enough To Prevent An Upgrade (NYSE:OFG) Vaxcyte: Vaccine Titan In The Making (NASDAQ:PCVX)
